Shelf life (days): 1460.0
Formulation: A crystalline solid
Formal Name: 5-[[(4S)-4-hydroxy-4-methyl-2-isoxazolidinyl]carbonyl]-3-methyl-1-(1-methylethyl)-6-[[5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl]-thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione
Purity: ≥95%
Formula Markup: C21H24F3N5O5S
Formula Weight: 515.5
CAS Number: 1448671-31-5
Notes: AZD 3965 is a potent inhibitor of monocarboxylate transporter 1 (MCT1; Ki = 1.6 nM), killing tumor cells that are reliant on glycolysis by blocking lactate transport.{32004} It displays six-fold selectivity for MCT1 over MCT2 and is without effect against MCT4 at 10 µM. AZD 3965 increases intratumor lactate levels and decreases tumor growth in mice bearing COR-L103 small cell lung cancer (SCLC) xenografts.{32004} AZD 3965 also enhances radiosensitivity in mice with SCLC xenografts.{32003}